近期,Tenaya Therapeutics Inc.(NASDAQ:TNYA)的主要股东The Column Group完成了一笔重大普通股收购交易。该交易于2025年3月5日进行,以每股0.70美元的价格购入35,714,284股股票,总价值约2500万美元。此次收购发生之际,该公司股价在过去一年已下跌近93%。根据 InvestingPro ...
2 天
Mediaite on MSNTrump Ripped for Pursuing ‘Stupid, Irrelevant Indulgences’ in Scathing National Review ...President Donald Trump "is at risk of blowing his second term before it has hit the two-month mark," wrote National Review ...
What a gift to find this “fan mail” now on the 16th anniversary of writing this column. Mom had no qualms about my Senior ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果